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Abstract
A better understanding of the initial mechanisms that lead to
arthritic disease could facilitate development of improved
therapeutic strategies. We characterized the synovial
microcirculation of knee joints in susceptible mouse strains
undergoing intradermal immunization with bovine collagen II in
complete Freund's adjuvant to induce arthritis (i.e. collagen-
induced arthritis [CIA]). Susceptible DBA1/J and collagen II T-
cell receptor transgenic mice were compared with CIA-resistant
FVB/NJ mice. Before onset of clinical symptoms of arthritis, in
vivo fluorescence microscopy of knee joints revealed marked
leucocyte activation and interaction with the endothelial lining of
synovial microvessels. This initial inflammatory cell response
correlated with the gene expression profile at this disease stage.
The majority of the 655 differentially expressed genes belonged
to classes of genes that are involved in cell movement and
structure, cell cycle and signal transduction, as well as
transcription, protein synthesis and metabolism. However, 24
adhesion molecules and chemokine/cytokine genes were
identified, some of which are known to contribute to arthritis
(e.g. CD44 and neutrophil cytosolic factor 1) and some of which
are novel in this respect (e.g. CC chemokine ligand-27 and IL-
13 receptor α 1). Online in vivo data on synovial tissue
microcirculation, together with gene expression profiling,
emphasize the potential role played by early inflammatory events
in the development of arthritis.
Introduction
Murine collagen-induced arthritis (CIA) is a chronic inflamma-
tory disease that bears all the hallmarks of rheumatoid arthritis
(RA), namely polyarthritis and synovitis with subsequent carti-
lage and bone erosions [1]. CIA is induced in susceptible
strains of mice (e.g. DBA1/J) by immunization with bovine col-
lagen type II in complete Freund's adjuvant (CFA). The devel-
opment of CIA is thought to depend on T cells, and disease
susceptibility is linked to the major histocompatibility region
[2]. Activated lymphocytes migrate to the joint, where an
inflammatory cascade involving T cells, macrophages, mono-
cytes, B cells and activated synoviocytes is triggered. This cel-
lular infiltration, together with production of a complex array of
cytokines and other soluble mediators, contributes to synovial
proliferation, pannus formation, cartilage destruction and
subchondral bone erosion [3].
Because the inflammatory process within joint tissues repre-
sents a key feature of RA, an understanding of the mecha-
nisms that induce and sustain this aspect of RA pathology
would permit development of new and powerful therapeutic
strategies. With direct online visualization, the technique of
intravital fluorescence microscopy permits dissection of the
complex cell inflammatory response, with differentiation
between cellular subtypes and their distinct adhesion mole-
cule dependent interactions within the microcirculation.
AIA = antigen-induced arthritis; CCL = CC chemokine ligand; CFA = complete Freund's adjuvant; CIA = collagen-induced arthritis; GO = Gene 
Ontology; IL = interleukin; mBSA = methylated bovine serum albumin; NCF = neutrophil cytosolic factor; RA = rheumatoid arthritis; TCR = T-cell 
receptor; TNF = tumour necrosis factor; VRBC = centre line red blood cell velocity.Arthritis Research & Therapy    Vol 7 No 4    Gierer et al.
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The approach of in vivo microscopy has successfully been
applied in joints of mice with antigen-induced arthritis (AIA)
[4]. AIA is established in mice by immunizing them with meth-
ylated bovine serum albumin (mBSA) in CFA with or without
an arthritogenic infectious agent at days 0 and 7, followed by
intra-articular injection of mBSA at day 21 [5]. Although AIA is
an established animal model for the study of human RA [6],
arthritis is more commonly induced using collagen, and this
represents the primary animal model for RA in humans [7-9].
Therefore, we employed in vivo microcirculatory analysis of
knee joints in mice with CIA, using different strains that are
known to acquire CIA, such as DBA1/J mice and T-cell recep-
tor (TCR) transgenic mice that carry the rearranged Vα 11.1
and Vβ 8.2 chain genes isolated from a type II collagen-specific
T-cell hybridoma (DBA-CII-TCR Tg) [10]. FVB/NJ mice were
used as controls, because these mice have been reported to
be resistant to arthritis induction, probably because of a
genomic deletion of TCR Vβ  gene segments [11].
Because we were particularly interested in the disease initia-
tion stage, the synovial microcirculation was assessed before
the onset of clinical symptoms of arthritis. We further charac-
terized the global gene expression profile at this early stage in
the disease in order to define the initial molecular mechanisms
and to determine the onset of joint inflammation.
Materials and methods
Animal model
The experimental protocol was approved by the local animal
rights protection authorities (LVL M-V/TSD/7221.3-1.1-037/
04) and followed the National Institutes of Health guidelines
for the care and use of laboratory animals. DBA1/J and FVB/
NJ mice were obtained from the Jackson Laboratory (Bar Har-
bor, ME, USA). Collagen II specific TCR transgenic mice were
a kind gift from Professor Ladiges, University of Washington,
USA [10]. All mice were kept under standard conditions at the
animal care facility of the University of Rostock.
Mice aged 8 weeks (n = 5–10 per strain and group) were
immunized intradermally at the base of the tail with 125 µg
bovine collagen II (Chondrex, Redmond, WA, USA) emulsified
in CFA (DIFCO, Detroit, MI, USA) or with equivalent volumes
of CFA only. Six weeks after immunization and before clinical
signs of arthritis manifested, animals were anaesthetized with
ketamine (90 mg/kg body weight) and xylacin (6 mg/kg) and
placed on a heating pad to maintain their body temperature at
37°C. A catheter was placed in the left jugular vein for appli-
cation of fluorescent dyes.
For in vivo multifluorescence microscopy of synovial microcir-
culation, we used the knee joint model initially described by
Veihelmann and coworkers [4]. Briefly, the skin was incised
distal to the patella tendon. After removal of the overlying soft
tissues, the patella tendon was transversally cut and the prox-
imal and distal part carefully mobilized. After exposure, the
'Hoffa's fatty body' was superfused with 37°C warm physio-
logical saline solution to prevent the tissues from drying and
finally covered with a glass slide. Following a 15-min stabiliza-
tion period after surgical preparation, in vivo microscopy of the
synovial tissue was performed. At the end of the experiments,
animals were killed by exsanguination. The complete knee joint
was excised and harvested for subsequent histology. Paws
were used for gene expression profile analysis.
Clinical evaluation of arthritis
As described by Nanakumar and coworkers [12], scoring of
animals was done blindly using a scoring system based on the
number of inflamed joints in each paw, inflammation being
defined by swelling and redness. In this scoring system each
inflamed toe or knuckle is attributed 1 point, whereas an
inflamed wrist or ankle is attributed 5 points, resulting in a
score of 0 to 15 (five toes + five knuckles + one wrist/ankle)
for each paw and 0–60 points for each mouse [12].
In vivo fluorescence microscopy
After intravenous injection of FITC-labelled dextran (15 mg/kg
body weight; Sigma, Deisenhofen, Germany) and rhodamine
6G (0.15 mg/kg body weight; Sigma), in vivo microscopy was
performed using a Zeiss microscope (Axiotech vario 100HD;
Carl Zeiss, Oberkochen, Germany) equipped with a 100 W
mercury lamp and filter sets for blue (excitation 465–495 nm,
emission >505 nm) and green (excitation 510–560 nm, emis-
sion >575 nm) epi-illumination. Using water-immersion objec-
tives (×20 W/numerical aperture 0.5 and ×40 W/numerical
aperture 0.8; Carl Zeiss), final magnifications of 306× and
630× were achieved. Images were recorded by means of a
charge-coupled device video camera (FK 6990-IQ-S; Pieper,
Schwerte, Germany) and transferred to a S-VHS video system
for subsequent offline analysis.
Microcirculatory analysis
For quantitative offline analysis a computer-assisted microcir-
culation image analysis system was used (CapImage v7.4;
Zeintl, Heidelberg, Germany). Functional capillary density was
defined as the total length of red blood cell perfused capillar-
ies per observation area, and is given in cm/cm2. For assess-
ment of leucocyte–endothelial cell interaction in postcapillary
venules, flow behaviour of leucocytes was analyzed with
respect to free floating, rolling and adherent leucocytes. Roll-
ing leucocytes were defined as those cells moving along the
vessel wall at a velocity less than 40% that of leucocytes at the
centre line, and are expressed as a percentage of the total leu-
cocyte flux. Venular leucocyte adherence was defined as the
number of leucocytes not moving or detaching from the
endothelial lining of the venular vessel wall during an observa-
tion period of 20 s. Assuming cylindrical microvessel geome-
try, leucocyte adherence was expressed as nonmoving cells
per endothelial surface (n/mm2), calculated from the diameter
and length of the vessel segment analyzed. In postcapillary
venules, centre line red blood cell velocity (VRBC) wasAvailable online http://arthritis-research.com/content/7/4/R868
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determined using the line shift method (CapImage; Zeintl, Hei-
delberg, Germany). The wall shear rate was calculated based
on the Newtonian definition: y = 8 × Vmean/D, where Vmean is
the mean velocity (VRBC/1.6) and D is diameter of the individ-
ual microvessel.
Laboratory analysis
Arterial blood samples were drawn for analysis of blood cell
counts using a Coulter Counter (AcTdiff; Coulter, Hamburg,
Germany).
Sample preparation for high-density oligonucleotide 
microarray hybridization
Paws of DBA/1J mice immunized with CFA or CFA/collagen II
and unimmunized mice were dissected and snap frozen in liq-
uid nitrogen, and total RNA was extracted using a commer-
cially available system (Qiagen, Hilden, Germany). RNA
probes were labelled in accordance with the manufacturer's
instructions (Affymetrix, Santa Clara, CA, USA). Analysis of
gene expression was conducted using the U430A array
(Affymetrix), which has a capacity of about 20,000 genes.
Samples from individual mice were hybridized onto individual
arrays. Hybridization and washing of gene chips were done in
accordance with the manufacturer's instructions and were as
described previously [13]. Microarrays were analyzed by laser
scanning and the expression levels were calculated using
commercially available software provided by Affymetrix [13].
The files were then analyzed using the affylmGUI package of
the Bioconductor software suite (Affymetrix) [14,15]. The
expression was determined using the robust multichip average
method [16]. A linear model of the expression data for Limma
was created within affylmGUI, for which the six arrays of mice
immunized with CFA/collagen II, the three arrays for mice
administered CFA only, and the two arrays for control mice
were separated into three groups. Contrasts were calculated
for each group against the other two.
The expression data are available in Additional files 1, 2, 3.
Genes considered differentially expressed were selected on
the basis of P value (<0.001) and a 1.5-fold change in inten-
sity (abs [M value] = log2 [1.5]). These genes are presented
in Additional file 4. Gene Ontology (GO) terms were assigned
to the selected genes (Fig. 1 and Additional file 4) via the Bio-
conductor GO package 1.6.8 and the chip annotation pack-
age MOE430a of the same version [17]. The Bioconductor
GO package provides lists of reachable subterms for each
GO term. We used this function to filter genes associated with
adhesion, specifically those assigned to 'adhesion offspring'
for any term in the following list: GO:0005125 (cytokine activ-
ity), GO:0006955 (immune response), GO:0050776 (regula-
tion of immune response), GO:0004895 (cell adhesion
receptor activity), GO:0007155 (cell adhesion),
GO:0016337 (cell–cell adhesion), GO:0030155 (regulation
of cell adhesion), GO:0050839 (cell adhesion molecule bind-
ing), GO:0030155 (regulation of cell adhesion),
GO:0019955 (cytokine binding), GO:0005912 (adherens
junction), GO:0005925 (focal adhesion), GO:0050900
(immune cell migration), GO:0030595 (immune cell chemo-
taxis), GO:0006954 (inflammatory response) and
GO:0006935 (chemotaxis).
Histology
At the end of each experiment, knee joints were fixed in 4%
phosphate-buffered formalin for 2–3 days, decalcified in
EDTA for 6 weeks, and then embedded in paraffin. From the
paraffin-embedded tissue blocks, 4 µm sections were cut and
stained with haematoxylin–eosin for histological analysis. For
semiquantitative analysis, the score described by Brackertz
and coworkers [6] was used (0 = normal knee joint; 1 = occa-
sional mononuclear cells in normal synovium; 2 = perivascular
leucocyte infiltration, two or more synovial cell layers; 3 =
dense infiltration of leucocytes, synovial hyperplasia; 4 = syn-
ovitis, pannus formation and cartilage erosions). The analysis
was done by a blinded and independent observer.
Statistical analysis of microcirculatory data
Results are presented as mean ± standard error of the mean.
After proving the assumption of normality, comparisons
between the experimental groups were performed by one-way
analysis of variance, followed by the appropriate post hoc mul-
Figure 1
Summary of differentially expressed genes at the early stage of arthritis Summary of differentially expressed genes at the early stage of arthritis. 
Of the approximately 22,000 genes on the Affymetrix chip MOE430a, 
655 genes were significantly differentially expressed (minimum 1.5-fold; 
P < 0.001) in a particular comparison: complete Freund's adjuvant 
(CFA)/collagen II versus CFA, CFA/collagen II versus no treatment, or 
CFA versus no treatment. Genes differentially expressed in more than 
one comparison are shown.Arthritis Research & Therapy    Vol 7 No 4    Gierer et al.
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tiple comparison procedure, including Bonferroni correction
(SigmaStat; Jandel, San Rafael, CA, USA). P < 0.05 was con-
sidered statistically significant.
Results
Gene expression profile in joints at onset of arthritis
To define the gene expression profile at early stages of CIA,
we used the murine Affymetrix oligonucleotide microarray
Table 1
Summary of adhesion molecules and chemokines/cytokines differentially expressed in CIA joints at early stages of disease and 
their GO terms.
Affymetrix ID Change Gene ID Description Go Term/Function
Solely changed in comparison CFA/collagen II versus CFA
1423760_at Up Cd44 CD44 antigen GO:0007155 cell adhesion
Solely changed in comparison CFA/collagen II versus no treatment
1422103_a_at Dn Stat5b Signal transducer and activator of 
transcription 5B
GO:0030155 cell adhesion
1423166_at - Dn Cd36 CD36 antigen GO:0007155 cell adhesion
1427165_at - Up Il13ra1 IL-13 receptor alpha 1 GO:0004907 IL activity
1434044_at - Dn Repin1 Replication initiator 1 GO:0006954 inflammatory response
1452483_a_at Up Cd44 CD44 antigen GO:0007155 cell adhesion
1452514_a_at Dn Kit Kit oncogene GO:0006935 chemotaxis
Solely changed in comparison CFA versus no treatment
1416156_at Dn Vcl Vinculin GO:0005912 adherens junction
1417705_at Dn Otub1 OTU domain, ubiquitin aldehyde 
binding 1
GO:0006955 immune response
1422873_at Dn Prg2 Proteoglycan 2, bone marrow GO:0006955 immune response
1430375_a_at Up Ccl27 Chemokine (CC motif) ligand 27 GO:0008009 chemokine activity
1437807_x_at Dn Catna1 Catenin α 1 GO:0005912 adherens junction
1452020_a_at Up Siva CD27 binding protein GO:0005175 CD27 receptor binding
1455158_at Dn Itga3 Integrin α 3 GO:0007155 cell adhesion
Changed in comparisons CFA/collagen II vs. CFA and CFA vs. no treatment
1450488_at Dn-Up Ccl24 Chemokine (CC motif) ligand 24 GO:0008009 chemokine activity
Changed in comparisons CFA/collagen II vs. no treatment and CFA vs. no treatment
1419329_at Dn Dn Sh3d4 SH3 domain protein 4 GO:0007155 cell adhesion
1420465_s_at Up Up Mup1 Major urinary protein 1 GO:0016068 type I hypersensitivity
1420553_x_at Dn Dn Serpina1a Serine proteinase inhibitor, clade A, 
member 1a
GO:0006953 acute-phase response
1423017_a_at Up Up Il1rn IL-1 receptor antagonist GO:0006955 immune response
1423734_at Up Up Rac1 RAS-related C3 botulinum substrate 1 GO:0007155 cell adhesion
GO:0006954 inflammatory response
1423885_at Dn Dn Lamc1 Laminin γ 1 GO:0007155 cell adhesion
1427164_at Up Up Il13ra1 IL-13 receptor α 1 GO:0004907 IL activity
1435148_at Dn Dn Atp1b2 ATPase, Na+/K+ transporting, β 2 
polypeptide
GO:0007155 cell adhesion
1448303_at Dn Dn Gpnmb Glycoprotein nmb GO:0007155 cell adhesion
1451767_at Up Up Ncf1 Neutrophil cytosolic factor 1 GO:0006954 inflammatory response
Shown are differentially expressed genes associated with adhesion or inflammation with respect to Gene Ontology (GO) terms. The genes are a 
subset of those shown in the Venn diagram (Fig. 1). The first column gives the probe set identification number (ID) of the Affymetrix chip Moe430a. 
The second column lists whether the gene is significantly upregulated (Up) or downregulated (Dn; minimum 1.5-fold) in a particular comparison, 
ordered complete Freund's adjuvant (CFA)/collagen II versus CFA, CFA/collagen II versus no treatment, and CFA versus no treatment. Columns 
three to five show the gene symbol, its name and GO terms. For further details, see Materials and method. IL, interleukin.Available online http://arthritis-research.com/content/7/4/R868
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MOE430a, with more than 20,000 gene specificities, to com-
pare the three groups of mice (i.e. CFA/collagen II immunized,
CFA immunized and unimmunized). As shown in Additional
files 1, 2, 3, 4 and Fig. 1, 655 genes were differentially
expressed between groups and taking a P < 0.001 as the
threshold for significance.
Interestingly, CFA alone induced the greatest number of differ-
entially expressed genes (i.e. 498). A total of 375 genes over-
lapped between different groups, and 280 were unique to a
certain group of mice (Additional file 4). When grouped
according to their probable function (i.e. GO terms), the major-
ity of the differentially expressed genes fell into classes of
genes involved in cell movement and structure, cell cycle and
signal transduction, as well as transcription, protein synthesis
and metabolism. One prominent group was that of adhesion
molecules and chemokine/cytokine-related genes. Twenty-
four genes belonging to this group were identified and are
summarized in Table 1 (Additional file 4). Some genes are well
known for their contribution to cell activation, cell–cell commu-
nication and chemotaxis, such as CD44, CD36, IL-1 receptor
antagonist and neutrophil cytosolic factor (NCF)-1, as well as
CC and CXC chemokines (Table 1, Additional file 4).
Systemic parameters
The animals from the CFA/collagen II immunized and the CFA
immunized groups did not differ with respect to haemoglobin
and haematocrit (Table 2). Moreover, there were no differ-
ences in blood cell counts between the two groups (Table 2).
Microvascular perfusion in synovial tissue
Functional capillary density did not differ significantly between
the experimental groups (Fig. 2), although there was a ten-
dency toward lower values in the DBA mice, and in particular
the TCR transgenic mice, after CFA/collagen II exposure (Fig.
2). Capillary diameters increased and VRBC decreased in all
animals exposed to CFA/collagen II exposure compared with
those subjected to CFA control treatment (Table 3). Wall
shear rates were found to be reduced in the CFA/collagen II
treated mice in comparison with those treated with CFA (Table
3).
Inflammatory cell response in synovial tissue
Although the animals exhibited no clinical symptoms of
arthritic disease, synovial tissue was characterized by an
inflammatory cell response with significant (P  < 0.05)
increases in leucocytes, both rolling along and firmly attaching
to the venular endothelium, in DBA and TCR transgenic mice
Table 2
Haemoglobin, haematocrit and blood cell counts following CFA or CFA/collagen II exposure
CFA CFA/collagen II
FVB DBA TCR FVB DBA TCR
Haemoglobin (mmol/l) 6.5 ± 0.4 7.1 ± 0.4 7.1 ± 0.4 7.1 ± 0.2 7.7 ± 0.3 7.9 ± 0.1
Haematocrit (%) 36 ± 2 43 ± 3 41 ± 3 40 ± 1 47 ± 2 46 ± 1
Thrombocytes (109/l) 851 ± 96 447 ± 73 551 ± 124 984 ± 210 729 ± 124 743 ± 111
Leucocytes (109/l) 3.8 ± 0.5 4.4 ± 0.9 2.1 ± 0.8 1.8 ± 0.5 4.9 ± 1.0 3.7 ± 0.7
Lymphocytes (%) 76 ± 5 80 ± 3 70 ± 3 65 ± 2 65 ± 4 65 ± 5
Mixed population (%) 14 ± 1 11 ± 2 26 ± 4 25 ± 3 32 ± 5 30 ± 4
Neutrophils (%) 6 ± 4 4 ± 1 5 ± 1 10 ± 3 3 ± 1 5 ± 2
Values are expressed as mean ± standard error. Blood samples were drawn at 6 weeks after complete Freund's adjuvant (CFA)- and CFA/
collagen II exposure. TCR, T-cell receptor.
Figure 2
Functional capillary density Functional capillary density. Shown is the functional capillary density of 
the synovium in complete Freund's adjuvant (CFA)/collagen II exposed 
FVB/NJ, DBA1/J and T-cell receptor (TCR) transgenic mice (collagen 
+) in comparison with CFA treated controls (collagen -). Intravital fluo-
rescence microscopy of the knee joints was performed at 6 weeks after 
collagen exposure for induction of arthritis. Values are expressed as 
means ± standard error (n = 5–10 animals/group).Arthritis Research & Therapy    Vol 7 No 4    Gierer et al.
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(Figs 3 and 4). In contrast, CIA-resistant FVB animals did not
organ pathologies, the activation of circulating leucocytes, and
their interaction with the endothelial lining followed by subse-
quent transendothelial migration and infiltration into tissue rep-
resent the first and determining step in a complex sequence of
processes that mediate tissue injury [18-20]. In contrast to our
previous study addressing the expression profile of joints in
CIA mice at the peak of the disease [13], we intentionally
focused on an early stage in the disease, in which the animals
were free of clinical symptoms. Although arthritic disease with
establishment of pannus tissue is dominated by genes that are
involved in cell division and proliferation, rather than immuno-
logically relevant genes [13], early disease appears to be char-
acterized by distinct upregulation of a group of chemotactic
and adhesion molecules, such as CD44 and IL-13 receptor
α 1, as well as CC chemokine ligand (CCL)-24 and CCL-27,
which presumably are responsible for cell attraction within the
joint microcirculation. Many of those molecules were induced
by both CFA and CFA/collagen II treatment, which is unsur-
prising because CFA is essential for induction of CIA.
Interestingly, the only upregulated adhesion molecule in the
comparison between mice treated with CFA/collagen II and
those treated with CFA alone was CD44, supporting a role for
CD44 in this early stage of arthritis. Indeed, there is
Figure 3
Leucocytes rolling along the endothelium of postcapillary synovial  venules Leucocytes rolling along the endothelium of postcapillary synovial 
venules. Shown are the proportions of leucocytes rolling along the 
endothelium of postcapillary synovial venules (as % of all passing leu-
cocytes) in complete Freund's adjuvant (CFA)/collagen II exposed 
FVB/NJ, DBA1/J and T-cell receptor (TCR) transgenic mice (collagen 
+) in comparison with CFA treated controls (collagen -). Intravital fluo-
rescence microscopy of the knee joints was performed at 6 weeks after 
collagen exposure for induction of arthritis. Values are expressed as 
means ± standard error (n = 5–10 animals/group); analysis of variance, 
unpaired post hoc comparison test: #P < 0.05 versus corresponding 
CFA-treated control animals (collagen -).
Figure 4
Leucocytes adherent to the endothelium of postcapillary synovial  venules Leucocytes adherent to the endothelium of postcapillary synovial 
venules. Shown are the numbers of leucocytes adherent to the 
endothelium of postcapillary synovial venules (cells/mm2 endothelial 
surface) in complete Freund's adjuvant (CFA)/collagen II exposed FVB/
NJ, DBA1/J and T-cell receptor (TCR) transgenic mice (collagen +) in 
comparison with CFA treated controls (collagen -). Intravital fluores-
cence microscopy of the knee joints was performed at 6 weeks after 
collagen exposure for induction of arthritis. Values are expressed as 
mean ± standard error (n = 5–10 animals/group); analysis of variance, 
unpaired post hoc comparison test: #P < 0.05 versus corresponding 
CFA-treated control animals (collagen -).
Table 3
Capillary diameter, venular red blood cell velocity and wall shear rates in synovial tissue following CFA or CFA/collagen II exposure
CFA CFA/collagen II
FVB DBA TCR FVB DBA TCR
Capillary diameter (µm) 4.3 ± 0.1 4.5 ± 0.2 4.4 ± 0.1 4.5 ± 0.1 4.7 ± 0.1 4.6 ± 0.1
VRBC (µm/s) 840 ± 143 1085 ± 350 1760 ± 412 620 ± 278 835 ± 251 487 ± 122*
Wall shear rate (s-1) 0.20 ± 0.03 0.21 ± 0.05 0.40 ± 0.09 0.12 ± 0.03 0.18 ± 0.05 0.10 ± 0.02
Values are expressed as means ± standard error. *P < 0.05 versus corresponding complete Freund's adjuvant (CFA) treated control animals. 
TCR, T-cell receptor; VRBC, venular red blood cell velocity.Available online http://arthritis-research.com/content/7/4/R868
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considerable published evidence for CD44 involvement in
arthritis, although its exact role remains controversial [21,22].
In accord with the importance of adhesion molecules in devel-
opment of arthritis, frozen section binding assays in rheuma-
toid synovitis demonstrated that, apart from E-selectin and
counter receptors for β 1/β 2 integrins, P-selectin is the predom-
inant adhesion molecule, mediating monocyte binding to
inflamed synovial venules [23]. Similarly, increased cellular
infiltration and increased expression of E-selectin, intercellular
adhesion molecule-1, vascular cell adhesion molecule-1,
platelet/endothelial cell adhesion molecule-1, very late appear-
ing antigen-4, and Mac-1 were found in immunohistochemistry
of synovial tissue from patients with RA [24]. Veihelmann and
coworkers [25] demonstrated high numbers of adherent leu-
cocytes upon clinical manifestation of AIA in mice, regardless
of phase (acute, intermediate, or chronic) of disease. In
accordance with and extending the findings of the latter study,
we now show that leucocyte adhesion is apparent even if clin-
ical symptoms are still absent, underscoring leucocyte–
endothelial interaction as an integral part not only of the per-
petuation and propagation of disease but also of its initiation.
Apart from adhesion molecules, a few chemokines and inflam-
matory mediators were found among the genes predominantly
expressed in CIA mice in the present study. This is in accord-
ance with the common knowledge that the key mechanisms
underlying synovitis include inflammatory cell activation and
adhesion, as well as production of mediators such as
cytokines, chemokines and growth factors [26,27]. In particu-
lar, tumour necrosis factor (TNF)-α  and IL-1 regulate nuclear
factor-κ B inducible genes that control – apart from other fac-
tors – cell adhesion molecules, proinflammatory mediators and
immunomodulatory molecules. These properties established a
rationale for anticytokine therapeutics and their evaluation in
an extensive series of clinical trials [28]. Anti-TNF-α  therapy
has been shown to reduce expression of adhesion molecules
and to decrease cellularity of rheumatoid synovial tissue
[29,30], supporting the hypothesis that the anti-inflammatory
effect is due to a downregulation of cytokine-inducible vascu-
lar adhesion molecules with a consequent reduction in cell
traffic into joints.
A few molecules belonging to the category of chemokines and
inflammatory mediators were differentially expressed and
deserve further investigation. These are NCF-1, IL-13 receptor
α 1 and CCL-27. NCF-1 is a member of the NADPH (nicotina-
mide adenine dinucleotide phosphate, reduced form) oxidase
complex, which was recently identified as a susceptibility gene
for pristine-induced arthritis. However, its exact role in disease
remains unclear [31]. The chemokine ligand CCL-27 was
recently shown to bind the P-selectin glycoprotein ligand 1 –
a molecule that plays a role in homing of T lymphocytes [32].
The role played by the cytokine receptor IL-13 receptor α 1 in
arthritis has not been established, but its ligand, IL-13, has
been described as a cytokine with anti-inflammatory properties
in arthritis and was the target of experimental gene therapy
experiments [33].
Of interest, mice from the two strains studied did not differ
with respect to functional capillary density, averaging about
320 cm/cm2. Corresponding values were found in Balb/c
mice during acute and intermediate phases of AIA [21] but
were attributed to inflammation-associated angiogenesis,
because control animals had values well below 250 [4,21]. If
it were angiogenesis driven, this would not account for the
high functional capillary density in CFA treated control animals
of the present study. Thus, it is more likely that differences in
functional capillary density are simply due to the fact that dif-
ferent strains were used.
Conclusion
Our data suggest that upregulation of proinflammatory media-
tors and molecules facilitate leucocyte adhesion to the
endothelium and migration into tissue, thereby representing an
essential and primary step in the development of arthritis.
Although studies of early RA are few, because there is an
inherent delay before patients receive expert care, it has been
recognized that early intervention improves outcome. Thus, the
early innate immune response should be an ongoing focus of
future research to determine whether leucocyte activation pre-
dicts severity of disease and is the earliest change to occur in
rheumatoid synovium.
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